Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4 is a type I transmembrane glycoprotein that functions as a co-receptor for the T-cell receptor (TCR) on helper T cells. It binds to MHC class II molecules on antigen-presenting cells (APCs), enhancing TCR signaling and facilitating the formation of immunological synapses. CD4 plays a crucial role in directing naive CD4+ T cell differentiation and is the primary receptor for HIV entry into host cells.
CD4 is targeted by HIV entry inhibitors, which block the virus from binding to CD4 and entering the cell.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of Differentiation Antigen 4 (CD4).